GBS cases rise in India: Is it deadly? What are key symptoms and the treatment process? Here is all about the syndrome
A 40-year-old man suspected of having Guillain-Barre Syndrome (GBS) died in Solapur, Maharashtra. Over 100 cases of GBS have ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
Long COVID patients frustrated by lack of new treatments
Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.